Business · 15/07/2008Updated: 10/17/2026 · 1 min read

FDA Announces Guidance for Industry: Current Good Manufacturing Practice for Phase 1 Investigational Drugs

The Food and Drug Administration (FDA) has released a document providing guidance on applying current good manufacturing practice (CGMP) requirements to the manufacture of investigational new drugs used in phase 1 clinical trials, effective July 2008.